Mometason Adgc (Mometasone Furoate Monohydrate)

Mometasone furoate binds to glucocorticoid receptors in nasal mucosal cells, altering gene transcription to suppress inflammatory cytokines, reduce vascular permeability, and decrease mucosal edema, thereby alleviating allergic inflammation.

The prescribed dose of Mometason Adgc is determined by the treating physician based on the patient’s age, severity of symptoms, and clinical response. Patients should follow the specific instructions provided by their healthcare professional.

Safety in pregnancy and lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mometason Adgc contains mometasone furoate, a potent glucocorticoid with high local anti‑inflammatory activity and minimal systemic absorption, comparable to other nasal steroids such as fluticasone propionate and budesonide, but may offer a different dosing frequency or patient‑preference profile.

Store the nasal spray at room temperature, ideally below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight and extreme temperatures to maintain product stability.

Mometason Adgc is administered as a nasal spray. The patient should gently blow the nose, insert the tip into one nostril, and spray the prescribed number of sprays while breathing in gently. The process is repeated in the other nostril if directed by the prescriber.

Serious risks, though rare, include nasal septal perforation, adrenal suppression leading to systemic corticosteroid effects, and severe allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience unusual bleeding, severe headache, visual changes, or signs of an allergic reaction.

Individuals with known hypersensitivity to mometasone furoate or any component of the formulation should avoid using Mometason Adgc. It is also contraindicated in patients with active untreated nasal infections or recent nasal surgery unless approved by a physician.